Streptolydigin: Difference between revisions
Appearance
Content deleted Content added
Updating {{drugbox}} (changes to verified fields - added verified revid - updated 'UNII_Ref', 'ChEBI_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report errors or [[user talk:CheMoBot|... |
changed chembl id |
||
Line 30: | Line 30: | ||
| ChemSpiderID = 16736035 |
| ChemSpiderID = 16736035 |
||
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
||
| ChEMBL = |
| ChEMBL = 1236068 |
||
<!--Chemical data--> |
<!--Chemical data--> |
Revision as of 11:37, 23 January 2012
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C32H44N2O9 |
Molar mass | 600.708 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Streptolydigin is an antibiotic which works by blocking nucleic acid chain elongation by binding to the polymerase, thus stopping RNA polymerase activity inside a cell. Specifically, it inhibits the assembly of the RNA polymerase II transcription complex and DNA polymerase III transcription. It is active against a number of gram positive bacteria.